ARTICLE | Company News
Clarient, CombiMatrix sales and marketing update
February 4, 2008 8:00 AM UTC
The companies partnered to market CombiMatrix's HemeScan MDS array-based tests to detect prognostic markers in chronic lymphocytic leukemia (CLL). Clarient will market the test to pathologists, oncolo...